These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16842385)

  • 21. [Are there indications for oral or sublingual administration of morphines?].
    Spielvogel C
    Cah Anesthesiol; 1994; 42(2):219-21. PubMed ID: 8087638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of opioids in the last week of life in an acute palliative care unit.
    Mercadante S; Ferrera P; Casuccio A
    Am J Hosp Palliat Care; 2010 Dec; 27(8):514-7. PubMed ID: 20439486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.
    Weschules DJ; Bain KT; Reifsnyder J; McMath JA; Kupperman DE; Gallagher RM; Hauck WW; Knowlton CH
    Pain Med; 2006; 7(4):320-9. PubMed ID: 16898943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
    Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
    Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of opioids in a Danish population-based cohort of cancer patients.
    Jarlbaek L; Andersen M; Hallas J; Engholm G; Kragstrup J
    J Pain Symptom Manage; 2005 Apr; 29(4):336-43. PubMed ID: 15857736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life].
    Yamazaki M; Aoki T; Tachibana M; Akashi T
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):217-21. PubMed ID: 16484859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Mangione S; Intravaia G
    Br J Cancer; 2007 Jun; 96(12):1828-33. PubMed ID: 17519902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
    Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use.
    Walsh D; Perin ML; McIver B
    Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial.
    Morita T; Takigawa C; Onishi H; Tajima T; Tani K; Matsubara T; Miyoshi I; Ikenaga M; Akechi T; Uchitomi Y;
    J Pain Symptom Manage; 2005 Jul; 30(1):96-103. PubMed ID: 16043013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Underdosing of morphine in comparison with other parenteral opioids in an acute hospital: a quality of care challenge.
    O'Connor AB; Lang VJ; Quill TE
    Pain Med; 2006; 7(4):299-307. PubMed ID: 16898939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Variable prescription of opioids to cancer patients in Norway].
    Olsen AS; Ottesen S
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1271-4. PubMed ID: 18511968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns.
    Finn J; Wright J; Fong J; Mackenzie E; Wood F; Leslie G; Gelavis A
    Burns; 2004 May; 30(3):262-8. PubMed ID: 15082356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of morphine prescription by doctors in a Nigeria tertiary hospital.
    Elumelu TN; Abdus-Salam AA; Adenipekun AA; Soyanwo OA
    Niger J Clin Pract; 2012; 15(1):27-9. PubMed ID: 22437084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
    Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U
    BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.